Clinical Trial Update: A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bosentan for exercise-induced pulmonary arterial hypertension in patients with connective tissue disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease
• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Hypertension, Pulmonary, Connective Tissue Disease | Phase 3 | Status: UNKNOWN